Ditchcarbon
  • Contact
  1. Organizations
  2. United Pharmaceutical Establishment
Public Profile
Pharmaceutical Preparation Manufacturing
SA
updated a month ago

United Pharmaceutical Establishment Sustainability Profile

Company website

United Pharmaceutical Establishment, commonly referred to as UPE, is a leading player in the pharmaceutical industry, headquartered in Saudi Arabia (SA). Established in 1993, UPE has made significant strides in the development and distribution of high-quality pharmaceutical products across the Middle East and North Africa (MENA) region. Specialising in a diverse range of therapeutic areas, UPE is renowned for its innovative formulations and commitment to quality. The company’s core offerings include prescription medications, over-the-counter products, and specialised healthcare solutions, all designed to meet the evolving needs of patients and healthcare providers. With a strong market presence and a reputation for excellence, United Pharmaceutical Establishment has achieved numerous accolades, solidifying its position as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does United Pharmaceutical Establishment's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

United Pharmaceutical Establishment's score of 20 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

24%

Let us know if this data was useful to you

United Pharmaceutical Establishment's reported carbon emissions

United Pharmaceutical Establishment, headquartered in Saudi Arabia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the organisation. This lack of data suggests that United Pharmaceutical Establishment may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for the company to consider developing and communicating its climate commitments to align with industry standards and expectations.

How Carbon Intensive is United Pharmaceutical Establishment's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. United Pharmaceutical Establishment's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is United Pharmaceutical Establishment's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for United Pharmaceutical Establishment is in SA, which has a medium grid carbon intensity relative to other regions.

United Pharmaceutical Establishment's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

United Pharmaceutical Establishment has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare United Pharmaceutical Establishment's Emissions with Industry Peers

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 21 hours ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Nahdi Medical Company

SA
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated about 1 month ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.4
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy